Elutia【ELUT】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

3.74

買値

2.30

売値

4.80

出来高

30,319

3.625 日の範囲 3.8714

2.15 52 週間の範囲 5.24

時価総額

129.262M

前日終値

3.89

始値

3.83

時刻

3.7

最終取引時間

財務取引量

US$ 114,945

VWAP

3.7912

平均取引量 (3 か月)

40,234

発行済株式数

34,562,098

配当利回り

PER

-3.42

1 株当たり利益 (EPS)

-1.09

歳入

24.75M

純利益

-37.66M

Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted ... Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection. 詳細を表示

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.elutia.com

本社

Wilmington, Delaware, USA

設立

Elutia Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker ELUT. The last closing price for Elutia was US$3.89. Over the last year, Elutia shares have traded in a share price range of US$ 2.15 to US$ 5.24.

Elutia currently has 34,562,098 shares in issue. The market capitalisation of Elutia is US$134.45 million. Elutia has a price to earnings ratio (PE ratio) of -3.42.

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

SILVER SPRING, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced it has been awarded a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

Over 100 EluPro VAC Submissions and 19% SimpliDerm Growth Drive Momentum into 2025 SILVER SPRING, Md., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”...

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

EluPro eradicated bacteria commonly associated with cardiac implant-related infections in an established preclinical infection model SILVER SPRING, Md., Sept. 18, 2024 (GLOBE NEWSWIRE...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.63	-14.4164759725	4.37	4.5	3.735	38193	4.15000419	CS
4	-0.75	-16.7037861915	4.49	5.12	3.3	50686	4.38430616	CS
12	-0.1	-2.60416666667	3.84	5.12	2.78	40234	3.98166387	CS
26	-1.25	-25.0501002004	4.99	5.24	2.28	49174	3.97233994	CS
52	1.59	73.9534883721	2.15	5.24	2.15	42118	3.78729248	CS
156	2.55	214.285714286	1.19	5.24	1.1	121166	2.17679967	CS
260	2.55	214.285714286	1.19	5.24	1.1	121166	2.17679967	CS

ELUT - Frequently Asked Questions (FAQ)

What is the current Elutia share price?

The current share price of Elutia is US$ 3.74

How many Elutia shares are in issue?

Elutia has 34,562,098 shares in issue

What is the market cap of Elutia?

The market capitalisation of Elutia is USD 134.45M

What is the 1 year trading range for Elutia share price?

Elutia has traded in the range of US$ 2.15 to US$ 5.24 during the past year

What is the PE ratio of Elutia?

The price to earnings ratio of Elutia is -3.42

What is the cash to sales ratio of Elutia?

The cash to sales ratio of Elutia is 5.21

What is the reporting currency for Elutia?

Elutia reports financial results in USD

What is the latest annual turnover for Elutia?

The latest annual turnover of Elutia is USD 24.75M

What is the latest annual profit for Elutia?

The latest annual profit of Elutia is USD -37.66M

What is the registered address of Elutia?

The registered address for Elutia is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Elutia website address?

The website address for Elutia is www.elutia.com

Which industry sector does Elutia operate in?

Elutia operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BDMDBaird Medical Investment Holdings Ltd	US$ 7.6699 (630.47%)	89.74M
APMAptorum Group Ltd	US$ 2.799 (106.57%)	116.74M
COEPCoeptis Therapeutics Holdings Inc	US$ 5.44 (75.48%)	5.08M
VRMEVerifyMe Inc	US$ 1.332 (68.63%)	94.04M
VEEETwin Vee PowerCats Company	US$ 0.55 (53.59%)	5.62M
WATTEnergous Corporation	US$ 1.00 (-62.26%)	29.33M
SGMOSangamo Therapeutics Inc	US$ 1.02 (-56.41%)	44.56M
INTZIntrusion Inc	US$ 3.07 (-45.95%)	15.07M
KZIAKazia Therapeutics Ltd	US$ 1.78 (-42.58%)	708.99k
TOIIWOncology Institute Inc	US$ 0.0052 (-42.22%)	366.02k
SVMHSRIVARU Holding Ltd	US$ 0.0423 (26.65%)	794.74M
XTIAXTI Aerospace Inc	US$ 0.0422 (6.84%)	446.31M
EYENEyenovia Inc	US$ 0.1474 (30.10%)	412.83M
CRKNCrown Electrokinetics Corporation	US$ 0.146899 (5.91%)	402.05M
ONCOOnconetix Inc	US$ 0.6479 (48.26%)	270.47M